Lifecore Biomedical Inc (LFCR)
5.78
-0.21
(-3.51%)
USD |
NASDAQ |
May 16, 16:00
5.78
0.00 (0.00%)
After-Hours: 20:00
Lifecore Biomedical Cash from Operations (TTM): -34.46M for May 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| May 31, 2023 | -17.44M |
| February 28, 2023 | -17.72M |
| November 30, 2022 | -22.77M |
| August 31, 2022 | -24.96M |
| May 31, 2022 | -22.59M |
| February 28, 2022 | -16.17M |
| November 30, 2021 | -6.291M |
| August 31, 2021 | 0.281M |
| May 31, 2021 | 16.47M |
| February 28, 2021 | -2.103M |
| November 30, 2020 | 16.34M |
| August 31, 2020 | 5.419M |
| May 31, 2020 | -17.04M |
| February 29, 2020 | -5.767M |
| November 30, 2019 | -3.705M |
| August 31, 2019 | 8.395M |
| May 31, 2019 | 16.02M |
| February 28, 2019 | 16.93M |
| November 30, 2018 | 18.25M |
| August 31, 2018 | 18.52M |
| May 31, 2018 | 19.78M |
| February 28, 2018 | 26.96M |
| November 30, 2017 | 30.65M |
| August 31, 2017 | 26.82M |
| May 31, 2017 | 29.84M |
| Date | Value |
|---|---|
| February 28, 2017 | 37.51M |
| November 30, 2016 | 24.01M |
| August 31, 2016 | 28.99M |
| May 31, 2016 | 20.76M |
| February 29, 2016 | 19.67M |
| November 30, 2015 | 25.55M |
| August 31, 2015 | 20.91M |
| May 31, 2015 | 26.62M |
| February 28, 2015 | 20.59M |
| November 30, 2014 | 20.10M |
| August 31, 2014 | 20.45M |
| May 31, 2014 | 21.04M |
| February 28, 2014 | 21.59M |
| November 30, 2013 | 23.14M |
| August 31, 2013 | 20.68M |
| May 31, 2013 | 21.23M |
| February 28, 2013 | 27.12M |
| November 30, 2012 | 25.31M |
| August 31, 2012 | 22.91M |
| May 31, 2012 | 22.18M |
| February 29, 2012 | 10.57M |
| November 30, 2011 | 11.66M |
| August 31, 2011 | 14.44M |
| May 31, 2011 | 14.47M |
| February 28, 2011 | 12.84M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-24.96M
Minimum
Aug 2022
16.47M
Maximum
May 2021
-5.508M
Average
-5.767M
Median
Feb 2020
Cash from Operations (TTM) Benchmarks
| Aquestive Therapeutics Inc | -25.58M |
| SELLAS Life Sciences Group Inc | -31.41M |
| ADMA Biologics Inc | 21.30M |
| Relmada Therapeutics Inc | -48.19M |
| Jaguar Health Inc | -33.24M |